CureVac nets EU funding to ramp up vaccine production – ZAWYA

CureVac nets EU funding to ramp up vaccine production – ZAWYA

CureVac nets EU funding to ramp up vaccine production | ZAWYA MENA Edition HomeEconomyGlobalArticleCureVac nets EU funding to ramp up vaccine production CureVac has started a phase I clinical trial of an experimental coronavirus vaccine in Germany and Belgium    An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020.BERLIN - German biotech company CureVac, which is developing a potential COVID-19 vaccine, has secured a 75 million euro ($85 million) loan from the European Investment Bank to boost its manufacturing capacity.The company, which is planning an initial public offering in the United States this month, said on Monday the loan will help it invest in its so-called messenger RNA approach technology and help it speed up construction of a fourth production site at its headquarters in Tuebingen, Germany.It is the second injection of new funding for the company in as many months, after the German government invested 300 million euros in a 23% holding in the firm in June to aid the development of its COVID-19 vaccine. The company, which is planning an initial public offering in the United States this month, said on